Market Research Blog

[151 Pages Report] According to a recent study by Future Market Insights (FMI), the global endovenous laser therapy market is expected to witness high growth during the forecast period. The market is expected to grow from US$ 378.3 Mn in 2021 to over US$ 811.1 Mn by 2031. This reflects a cumulative CAGR of around 7.9% over the forecast period (2022-2031).

Rise in number of varicose veins cases, availability of technologically advanced laser therapy, shift towards minimally invasive procedures and increasing product launches are the primary factors responsible for the growth of the market during the forecast period.

Varicose veins are more common in pregnant women, partially because the baby puts more pressure on the veins and partly because hormones generated during pregnancy relax vein walls. Varicose veins can develop as a result of damage to a deep leg vein. Over the projected period, rising instances of varicose veins are expected to drive revenue growth in the endovenous laser systems market.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2785

Another factor that is having a positive impact on endovenous laser therapy is the rapid change in lifestyle with no physical activity and labour across the globe, as well as the rise in the elderly population, both of which are anticipated to contribute to the global market’s growth over the forecast period. The market is also expected to develop due to the quick and effective technique as well as the growing demand for endovenous laser therapy.Moreover, growing prevalence of obesity worldwide is driving growth of the endovenous laser therapy market. Obesity leads to problems related to blood circulation which leads to varicose veins.

Medical device manufacturers operating in the endovenous laser therapy market are focusing on providing user friendly devices to the end users to minimize chances of manual errors. In addition, continuous launch of new and improved products and increasing investment in research and development by the manufacturers in endovenous laser therapy devices would lead to growth of global market over the forecast period.

Key Takeaways from Endovenous Laser Therapy Market Study

• Endovenous laser systems held the maximum share of 92.0% in 2021 by component, expanding at a rapid rate owing to the rising number of varicose veins cases and increase in number of product launches with advanced features.
• Ambulatory surgical centers showed maximum growth among all end users with a market share of 36.2% in 2021 owing to the rise in demand for outpatient surgeries. In countries such as the U.S., endovenous laser therapy for varicose veins is majorly performed in ambulatory surgical centers rather than hospitals in order avoid long-time waiting in big hospital settings, which is why the segment is developing at a rapid rate
• North America held the largest share of 42.7% of the global endovenous laser therapy market by region in 2021 indicating the growth due to increase in prevalence of obesity and growing number of FDA approvals in North America.

“Growing prevalence of varicose veins, shift towards minimally invasive procedures, availability of novel laser treatment and increasing number of product launches Is Expected to Drive the Demand for Endovenous Laser Therapy over the Decade,” says the FMI Analyst

 Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2785

Who is winning?

The key market players covered by FMI include AngioDynamics, Inc., Syneron Medical Ltd., Dornier MedTech GmbH, Alma Lasers Ltd., Alna-Medical system GmbH, LSO Medical, Wontech Co., Ltd., intros Medical Laser GmbH and Energist Ltd.

Some of the leading manufacturers of endovenous laser therapy market are focusing on product launch, approvals, collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

• In January 2021, Syneron Medical Ltd. announced the availability of the Frax Pro™ system. The FDA-cleared and CE-marked, non-ablative fractional device is the first platform featuring dual-depth skin resurfacing with both Frax 1550™ and the novel Frax 1940™ applicators.
• In July 2020, Wontech announced that ‘Picowon’, an alexandrite (755nm)-based pico laser, has obtained US Food and Drug Administration (FDA) approval for the first time in Asia and the second in the world.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global endovenous laser therapy market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on endovenous laser therapy segment based on product (Endovenous Laser Systems {Diode Lasers and YAG Lasers}, and Endovenous laser Fibers {Bare Tip Laser Fiber, Radial Tip Laser Fiber and Gold Tip Laser Fiber}), and end user (hospitals, ambulatory surgical centers and Specialized Clinics) across seven major regions.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2785

Endovenous laser therapy Market by Category By Product

• Endovenous Laser Systems
  • Diode Lasers
  • Yag Lasers
• Endovenous Laser Fibers
  • Bare Tip Laser Fibers
  • Radial Tip Laser Fiber
  • Gold tip Laser Fiber

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialized Clinics

By Region

• North America
• Latin America
• Western Europe
• Eastern Europe
• APEJ
• Japan
• Middle East & Africa

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[333 Pages Report] The pipette tips market is worth USD 680.40 million in 2022 and is expected to grow at an 8.0% CAGR from 2022 to 2032 to reach USD 1.47 billion by 2032.

Constant product innovation, rising demand for R&D, and an increasing number of healthcare settings, diagnostics, and liquid handling systems are key drivers driving pipette tips market growth as well as the pipette tips market opportunities.

Attributes	Details
Pipette Tips Market CAGR (2022-2032)	8.0%
Pipette Tips Market Size (2022)	USD 680.40 million
Pipette Tips Market Size (2032)	USD 1.47 billion

Furthermore, there has been an increase in the number of innovations in this product category, which is fuelling demand for pipette tips. Pipette tips, such as wide orifice tips, gel loading tips, standard, filtered, low-retention pipette tips, and so on, saw a significant increase in demand for pipette tips following the emergence of COVID-19 in 2020, as they were among the critical laboratory devices used to detect the virus’s presence.

Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15166

The filter tips product type segment of the pipette tips market in the United States is expected to grow at the fastest CAGR during the forecast period. The robotics segment had the largest pipette tips market share.

The demand for pipette tips increased dramatically as a result of the COVID-19 outbreak, as daily testing at diagnostic centres for infection detection increased influencing the pipette tips market adoption trends. However, many supply chain bottlenecks were encountered as demand for pipette tips outstripped supply.

Revenue from sales of pipette tips market increased significantly in the second half of 2020, particularly in the United States and Europe. Manufacturers of pipette tips are constructing a new plant for high-quality laboratory consumables made of functional high-tech polymers which will positively affect the pipette tips market key trends and opportunities as well as the pipette tips market future trends.

Eppendorf stated in its 2021 annual pipette tips market report that sales of pipette tips majorly its robotic pipetting systems have increased and have more than doubled since 2020. This suggests that demand for pipette tips notably robotic pipettes will rise as well along with the constructive effect on the pipette tips market future trends.

KEY TAKEAWAYS:

• The standard product segment dominates the pipette tips market in product insight. It accounts for 32.5% of total revenue and is expected to grow at a healthy rate in the future.
• In terms of technology insight, the non-robotic pipette tip segment is anticipated to have highest revenue in the pipette tips market share of 56.4% through 2032 and is expected to grow significantly during the forecast period.
• In terms of application insight, the pharma and biotech segment dominates the pipette tips market, accounting for 32.3% of total revenue. The segment is expected to grow at the fastest CAGR during the forecast period, maintaining its leading position in the pipette tips market.
• North America dominates the pipette tips market, accounting for 37.5% of the total revenue.

Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-15166

COMPETITIVE LANDSCAPE:

New market research report on pipette tips will offer valuable insight into the market, with a focus on some of the major players such as Thermo Fisher Scientific, Sartorius AG, CORNING INC., Mettler Toledo, Tecan Trading AG, Hamilton Company, Eppendorf AG, and others.

Pipette tips market participants’ key strategic initiatives include new product development, collaborations, regional expansions, and mergers.

RECENT DEVELOPMENT:

Collaboration:

• Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. announced a 15-year strategic collaboration agreement in 2022 to enable dedicated large-scale manufacturing in the United States of Spikevax, Moderna’s COVID-19 vaccine, and other investigational mRNA medicines in its pipeline, resulting in increased use of essential lab supplies such as pipette tips.

Expansion:

• Thermo Fisher Scientific announced a $140 million investment to expand its laboratory plastics disposables production in order to meet global demand for pipette tips during COVID-19 testing, as well as for the development and manufacturing of therapies and vaccines.

Acquisition:

• Sartorius has acquired Biological Industries Ltd., a manufacturer of cell culture and molecular biology research products.

For in-depth insights, Download a PDF Brochure@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15166

Key Segments

By Product:

• Standard
• Filtered
• Low-retention
• Others

By Technology:

• Robotic
• Non-robotic

By Applications:

• Diagnostics and Healthcare
• Pharma and Biotech
• Academia and Education
• Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

According to this new report titled “Dermal Fillers Market: Global Industry Analysis (2012-2016) and Opportunity Assessment” that tracks the performance of the global dermal fillers market for a period of 10 years, the United States is a highly mature market with wide scale adoption of dermal fillers.

The global dermal fillers market is traversing a path from the growth phase to maturity as companies are focussing on developing variants of products currently available in the global dermal fillers market.

This new report published by Future Market Insights discusses the high pricing competition and discounting practices between companies as well as physician practices that inflate margins and tend to hamper global adoption of the dermal filler procedure by patients.

Request Sample Report @

https://www.futuremarketinsights.com/reports/sample/rep-gb-5699

Multiple applications of dermal fillers and increasing number of aesthetic surgeons are the main factors responsible for fuelling the growth of the global dermal fillers market

Apart from functioning as an anti-aging factor, dermal fillers are also helpful in the areas of treatments such as acne scars, enhancement of the dorsal area of hand, and for HIV induced lipoatrophy of facial area.

Besides, the use of dermal fillers for the treatment of paralysed vocal cords is also under consideration for approval from the FDA.

The demand for application specific product modules is driving the growth of the global dermal fillers market.

Another important factor that is boosting the growth of the global dermal fillers market is a sudden increase in the number of plastic surgeons and their network.

This increasing network is boosting the demand for aesthetic procedures, which in turn is fuelling the development of the global market.

The FDA has also given its approval for the use of dermal fillers in the area of dentistry.

This is particularly beneficial for dentists as they come across many such cases that require facial changeover, which is easily possible with the help of dermal filler procedures.

The other drivers associated with dermal filler procedure include lesser procedure time, minimum risk of complexity, and requirement of minimum infrastructure.

Read Report Overview @ https://www.futuremarketinsights.com/reports/dermal-fillers-market

Increasing focus on development of new products and market expansion strategies by direct presence or through affiliates as a key development strategy by companies is expected to increase the demand for dermal fillers during the forecast period.

Favourable support from the government in terms of approval for new entities and new application areas as well as the commercialization of novel solutions are factors boosting collaborations and partnership agreements between manufacturers.

Various companies are also developing application specific dermal fillers and expanding their product range such as, fillers specific for lip augmentation, specific dermal fillers for the dorsal area of hand and fillers to increase volume.

All these factors are creating a robust development in the global market for dermal fillers.

Buy Full Dermal Fillers Market Research Report @ https://www.futuremarketinsights.com/checkout/5699

The application of dermal fillers in dentistry is expected to make an impact on the global market over the forecast period

With a Compound Annual Growth Rate of 3.4% during the period of assessment, the dentistry application segment is projected to grow significantly in terms of revenue in the years to come.

The key reason behind this growth is an increasing usage of the dermal filler procedure in the area of dentistry.

The aesthetic restoration segment dominated the dermal fillers market in terms of revenue in 2016 and this trend is projected to continue throughout the forecast period.

Reconstructive surgery is expected to be the second most lucrative application segment, given the high rate of growth of orthopaedic procedures across the globe.

Global Dermal Fillers Market: Overview

Our forecasts indicate that the global dermal fillers market is expected to grow from an estimated value of more than US$ 3,600 Mn in 2017 to just over US$ 4,960 Mn by the end of the forecast period in 2027.

This represents a CAGR of 3.2% in terms of revenue over the forecast period of 2017 to 2027. The global market for dermal fillers represents absolute $ opportunity of more than US$ 115 Mn in 2018 over 2017 and an incremental opportunity of more than US$ 1,300 Mn between 2017 and 2027.

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact: 

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Browse latest Market Reports: https://www.futuremarketinsights.com/reports

LinkedIn| Twitter| Blogs

[170 Pages Report] According to a recently compiled study by Future Market Insights, the global animal model market will reflect an impressive CAGR through the forecast period, 2017 to 2026. Revenues from the global market for animal model are poised to surpass US$ 2,200 Mn by 2026-end.

Future Market Insights (FMI), in a recent report estimates global PEEK interbody devices market to grow steadily through 2021, despite COVID-19 pandemic creating a shift in administered care. The study pegs growth to hover above 7% mark throughout the forecast period.

Polyether ether ketone interbody devices are a significant breakthrough in the medical industry, with various healthcare settings adopting them to streamline their spinal implantation procedures. Additionally, they are highly eco-friendly as they are manufactured from organic thermoplastic polymers.

Provision of a bone-like modulus, high radiolucency to ensure accuracy and greater biocompatibility have all contributed to increasing PEEK interbody devices adoption for spinal procedures, and is likely to remain so in the future.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12685

Polyether Ether Ketone Interbody Devices Market Size (2022)
US$ 2.04 Bn
Revenue Forecast (2030)
US$ 3.72 Bn
Global Market Growth Rate (2022-2030)
7.8% CAGR
Dominant End User
Hospitals (48.9%)
Key Takeaways

US to retain market dominance; East Asia to be 2nd largest market through 2030
Surging popularity of minimally invasive surgeries to escalate interbody fusion devices growth
Hospitals to be key PEEK interbody devices end-users from 2020-2030
Rapid advancements in spinal implants to facilitate greater adoption
Fast-track regulatory approvals expanding sales across prominent regions
Global PEEK interbody devices to expand at 7.7% CAGR through 2030
“High incidence of degenerative disc diseases and spinal stenosis among the geriatrics is facilitating rapid innovations in surgical procedures, providing a wide base for PEEK interbody device market expansion,” opines the FMI analyst.

COVID-19 Impact Insights

The novel coronavirus pandemic has had varying impacts across the global polyether ether ketone interbody devices market. In the first stage, strict lockdowns and social distancing measures led to a drastic decline in industrial output, creating immense shortages of the devices across various healthcare settings.

Furthermore, greater emphasis was laid on caring for COVID-19 positive patients, leading to postponement of elective surgical procedures such as spinal correction or implantation, causing a substantial decline.

As the incidence of infections receded, the market has been experiencing a gradual incline. Flattening infection curves have enabled countries to ease lockdown restrictions, leading to a resumption of output which has largely balanced the demand-supply equation.

Moreover, spinal implant procedures are resuming, with hospitals and clinics registering a fall in the number of SARS-CoV-2 patients. Considering this recovery scenario, the global PEEK interbody devices is anticipated to rebound starting from 2021.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-12685

Competition Landscape

Prominent players within the global PEEK interbody devices landscape are Zimmer Biomet, Medtronic Plc, Stryker Corporation and Shandong Weigo Group. These and other players are focusing on expanding existing manufacturing capabilities, product innovations, forays into untapped markets and strengthening core competencies.

In June 2020, Zimmer Biomet announced the incorporation of new enhanced features of its mymobility® care management system which was introduced in collaboration with Apple in October 2018. These features will assist healthcare professionals to enhance decision-making processes concerning major surgeries by incorporating higher precision.

In October 2020, Medtronic plc reported that over 84% of chronic back pain patients treated with its DTMTM Spinal Cord Stimulation Therapy reported at least 50% pain relief since the system’s inception a year earlier. This has encouraged the company to keep investing in better pain management technologies.

Key Segments

Product Type

Posterolateral Fusion Devices
Interbody Fusion Devices
Anterior Lumbar Interbody Fusion Devices (ALIF)
Extreme Lateral Interbody Fusion Devices (XLIF)
Posterior Lumbar Interbody Fusion Devices (PLIF)
Transforaminal Lumbar Interbody Fusion Devices (TLIF)
Other Devices

End-Users

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-12685

Region

North America (U.S & Canada)
Latin America (Brazil, Mexico, Argentina & Rest of Latin America)
Europe (Germany, Italy, France, U.K., Spain, BENELUX, Russia & Rest of Europe)
South Asia (India, Thailand, Indonesia, Malaysia & Rest of South Asia)
East Asia (China, Japan & South Korea)
Oceania (Australia & New Zealand)
Middle East & Africa (GCC, South Africa & Rest of MEA)